Armistice Capital, LLC Oncternal Therapeutics, Inc. Transaction History

Armistice Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$1.51 - $6.3 $1.99 Million - $8.29 Million	-1,316,163 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.7 - $3.28 $101,058 - $194,982	59,446 Added 4.73%	1,316,163 $2.24 Million
Q2 2020 Aug 14, 2020	BUY	$2.43 - $3.23 $3.05 Million - $4.06 Million	1,256,717 New	1,256,717 $3.57 Million

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.